*Kazutaka Ohi^1,2, Mihoko Shimada³, Midori Soda⁴, Daisuke Nishizawa⁵, Daisuke Fujikane¹, Kentaro Takai¹, Ayumi Kuramitsu¹, Yukimasa Muto¹, Shunsuke Sugiyama¹, Junko Hasegawa⁵, Kiyoyuki Kitaichi⁴, Kazutaka Ikeda⁵, Toshiki Shioiri¹ (1. Department of Psychiatry, Gifu University Graduate School of Medicine, 2. Department of General Internal Medicine, Kanazawa Medical University, Ishikawa, Japan, 3. Genome Medical Science Project (Toyama), National Center for Global Health and Medicine (NCGM), Tokyo, Japan, 4. Laboratory of Pharmaceutics, Department of Biomedical Pharmaceutics, Gifu Pharmaceutical University, Gifu, Japan, 5. Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan)

*Shoko Shimizu¹, Yugo Ishino¹, Shingo Miyata¹ (1. Research Institute of Traditional Asian Medicine, Kindai Univ, Osaka, Japan)

*Takuto Matsuda¹, Yuko Arioka^2,3, Hiroki Okumura^2,4, Daisuke Mori^2,5, Norio Ozaki² (1. Psychiatry, Grad Sch Med, Nagoya Univ, Nagoya, Japan, 2. Pathophysiology of Mental Disorders, Grad Sch Med, Nagoya Univ, Nagoya, Japan, 3. Center for Advanced Medicine and Clinical Research, Nagoya Univ Hospital, 4. Department of Hospital Pharmacy, Nagoya Univ Hospital, 5. Brain & Mind Research Center, Nagoya Univ, Nagoya, Japan)

*Ayumu Kawasaki¹, Takumi Nakamuara¹, Hirotaka Shoji³, Hirona Yamamoto¹, Kurara Honda¹, Tsuyoshi Miyakawa³, Nobuya Sasaki², Atsushi Takata¹ (1. RIKEN Center for Brain Science, 2. School of Veterinary Medicine, Kitasato University, 3. Center for Medical Science, Fujita Health University)